Search results
Oct 31, 2024 · Search the Ontario Drug Benefit Formulary/Comparative Drug Index, effective from October 31, 2024 using any or all of the criteria below.
Search Results. You can sort your results in ascending / descending order by clicking on the column headings, with the exception of Therapeutic Notes. Products found: 8161. New Search. DIN/ PIN/ NPN. Generic Name. Brand Name, Strength & Dosage Form. MFR. Drug Benefit Price or Unit Price.
Sep 29, 2023 · Search Results. You can sort your results in ascending / descending order by clicking on the column headings, with the exception of Therapeutic Notes. Products found: 1. DIN/ PIN/ NPN. Generic Name. Brand Name, Strength & Dosage Form. MFR. Drug Benefit Price or Unit Price. Amount MOH Pays.
Sep 30, 2019 · Novo Nordisk Canada Inc. Formulary Listing Date: 2019-09-30. Drug Benefit Price or Unit Price: 218.0300. Amount MOH Pays: 218.0300. Coverage Status:
Limited Use Note(s)
Sep 29, 2023 · Patients who continue to experience clinical attacks or increased lesions or worsening EDSS should be evaluated for appropriateness of therapy and consideration of other treatment options available on the ODB formulary or through the Exceptional Access Program.
Limited Use Note (s) Reason For Use Code. Clinical Criteria. 665. For the treatment of adult patients with type 2 diabetes when adequate glycemic control is not achieved on the maximum tolerated dose of metformin or where metformin is contraindicated or inappropriate.
Sep 29, 2023 · Find information on vancomycin drug products covered by the Ontario Drug Benefit Program, including coverage status and manufacturer details.
Sep 29, 2023 · Limited Use Note (s) History of a documented, clinically significant ulcer or GI bleed; or Failure or intolerance to at least three listed NSAIDS. NOTE: The maximum daily dose of celecoxib which will be reimbursed for the treatment of osteoarthritis is 200mg.
Interchangeable Grouping. You can sort your results in ascending / descending order by clicking on the column headings.
